XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (35,957,889) $ (8,211,297)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 3,277,569 3,314,781
Asset impairment charge 26,472,407
Gain on disposal of property and equipment (9,674)
Credit loss expense 459,233 230,930
Inventory obsolescence 489,572 356,261
Share-based compensation 3,972,788 3,240,362
Noncash lease expense 446,285 306,240
Share of losses from equity method investments 627,732 31,448
Back-end fee 578,901 219,689
Paid-in-kind interest 1,593,416 424,067
Accretion of finance liabilities 120,022 166,595
Amortization and write-off of debt issuance costs 206,363 150,219
Change in fair value of earnout liabilities 67,549
Changes in operating assets and liabilities:    
Accounts receivable, net (144,959) (2,777,243)
Accounts receivable – related parties 40,566 (35,009)
Inventory, net (1,122,497) 1,352,923
Prepaid and other assets 318,266 178,963
Accounts payable (359,968) (622,719)
Accounts payable – related parties (3,575) 72,806
Accrued royalties and expenses 403,767 249,910
Accrued bonuses and commissions 1,879,615 580,031
Operating lease liabilities (446,372) (252,337)
Net cash provided by (used in) operating activities 2,841,568 (955,831)
Cash flows from investing activities:    
Purchases of property and equipment (4,543,491) (133,676)
Proceeds from disposal of property and equipment 60,000
Purchases of intangible assets (23,452)
Investment in equity securities (5,899,524) (5,268,582)
Convertible loan receivable (1,079,391)
CarePICS Acquisition (2,122,146)
Net cash used in investing activities (12,528,613) (6,481,649)
Cash flows from financing activities:    
Loan proceeds, net of debt issuance costs of $228,183 in 2025 and $1,160,740 in 2024 12,021,817 29,339,260
Pay off line of credit   (9,750,000)
Pay off debt assumed in CarePICS Acquisition (1,650,000)
Equity offering net expenses (75,000)
Net settlement of equity-based awards (764,421) (87,807)
Cash payment of finance and earnout liabilities (859,000) (859,000)
Net cash provided by financing activities 8,748,396 18,567,453
Net increase (decrease) in cash (938,649) 11,129,973
Cash, beginning of period 15,878,295 5,147,216
Cash, end of period 14,939,646 16,277,189
Cash paid during the period for:    
Interest 2,428,062 948,759
Supplemental noncash investing and financing activities:    
Non-monetary exchange to acquire intangible assets 2,084,278
Conversion of note receivable into equity method investment 1,101,478
Earnout liability generated by CarePICS Acquisition 1,355,603
Right of use assets obtained in exchange for lease obligations $ 1,153,099